Status:
UNKNOWN
Effects of Inspiratory Muscle Training in Patients With Parkinson's Disease
Lead Sponsor:
Gazi University
Conditions:
Parkinson Disease
Eligibility:
All Genders
45-80 years
Phase:
NA
Brief Summary
Parkinson's patients usually have a significant decrease in respiratory muscle strength and respiratory function, which may increase in proportion to the severity of the disease. In addition, peripher...
Detailed Description
Parkinson's disease is the second most common neurodegenerative disease. The main motor symptoms seen in Parkinson's disease are tremors, rigidity, bradykinesia, and decreased postural reflexes. In ad...
Eligibility Criteria
Inclusion
- Between the ages of 45-80,
- Follow-up with a diagnosis of Parkinson's disease for more than six months
- Stages I-III according to the modified Hoehn and Yahr scale
- Parkinson's patients with independent walking capacity will be included.
Exclusion
- Having a neurological disease other than Parkinson's disease
- Patients with a diagnosed lung disease that may affect respiratory functions
- At least 10 pack years or more of smoking history
- According to the American Association of Sports Medicine (ACSM) with absolute and relative contraindications to exercise tests
- Those with a Mini-Mental State Rating Scale score of less than 18
- Patients with additional cardiac orthopaedic and psychological problems that limit the evaluation will be excluded from the study.
Key Trial Info
Start Date :
August 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06017336
Start Date
August 15 2023
End Date
February 15 2025
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Clinic
Ankara, Turkey (Türkiye), 06560